More work needed on AstraZeneca/Oxford Covid-19 vaccine trialsAstraZeneca, BioNTech, Clinical Studies, COVID-19 Vaccines, FDA, Moderna, Oxford University, Peer-reviewed data, Pfizer, Scientists, South Africa, The Lancet, United KingdomAstraZeneca and Oxford University have more work to do to confirm whether their Covid-19 vaccine can be 90% effective, peer-reviewed data published in The Lancet showed, potentially slowing its eventual rollout in the fight against the pandemic. Read more December 8, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/12/Testing-times-More-work-needed-on-AstraOxford-vaccine-trials-Reuters-12-8-20.jpeg 236 370 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-12-08 11:08:562020-12-08 18:57:17More work needed on AstraZeneca/Oxford Covid-19 vaccine trials